Background illustration for clinical trials search

Paid Clinical Trials Long Beach

Discover 3,601 paid clinical trials in Long Beach, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

for
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma,
Location: Fountain Valley CA, Orange CA, Irvine CA, La Jolla CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07431281

Phase 3, Recruiting

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

for
Osteoarthritis, Overweight or Obesity
Location: Fountain Valley CA, Santa Ana CA, Spring Valley CA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07353931

Phase 3, Recruiting

Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

for
Advanced Breast Cancer
Location: Fountain Valley CA, Los Angeles CA, Newport Beach CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06380751

Phase 3, Recruiting

A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer

for
Platinum-resistant Ovarian Cancer
Location: El Segundo CA, Newport Beach CA
Sponsor: ImmunityBio, Inc.

Sex: Female

Age: 18 - 70+

Code: NCT06710288

Phase 2, Recruiting

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

for
Systemic Sclerosis Associated Interstitial Lung Disease,
Location: Los Angeles CA, Upland CA, Scottsdale AZ, Tucson AZ,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT05878717

Phase 2, Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

GEMINI-NSCLC: NSCLC Biomarker Study

for
Non-Small Cell Lung Cancer
Location: Fountain Valley CA, Los Angeles CA, Las Vegas NV,
Sponsor: Tempus AI

Sex: All

Age: 18+

Code: NCT05236114

Recruiting

Stool Sample Collection Study

for
Colorectal Cancer
Location: Anaheim CA, Cordova TN, Ocala FL
Sponsor: Innovis LLC

Sex: All

Age: 18+

Code: NCT06294873

Recruiting

Randomized Withdrawal Study in Patients With Schizophrenia

for
Schizophrenia
Location: Pico Rivera CA, Costa Mesa CA, Oceanside CA,
Sponsor: Vanda Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT06961968

Phase 3, Recruiting

Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis

for
Primary Myelofibrosis (PMF),
Location: Whittier CA, Glendale CA, Houston TX, Canton OH
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04878003

Phase 2, Recruiting

ConsideRAte Study - Splenic Stimulation for RA

for
Rheumatoid Arthritis
Location: Whittier CA, Covina CA, Portland OR, Austin TX,
Sponsor: Galvani Bioelectronics

Sex: All

Age: 22 - 70+

Code: NCT05003310

Recruiting

Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

for
Metastatic Pancreatic Adenocarcinoma
Location: Whittier CA, Canton OH, Tampa FL
Sponsor: Eleison Pharmaceuticals LLC.

Sex: All

Age: 18+

Code: NCT01954992

Phase 3, Recruiting

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

for
Systemic Sclerosis
Location: Whittier CA, San Diego CA, Calgary, Austin TX,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07497087

Phase 3, Recruiting

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

for
Lymphoid Malignancies
Location: Whittier CA, Los Angeles CA, Duarte CA, Dallas TX,
Sponsor: AVM Biotechnology Inc

Sex: All

Age: 12 - 70+

Code: NCT04329728

Phase 1, Phase 2, Recruiting

PREDICT Therapy Selection for JAK, T-cell, or IL-6 Inhibitor Therapies Using a Molecular Signature Response Classifier (PREDICT)

for
Rheumatoid Arthritis
Location: Whittier CA
Sponsor: Scipher Medicine

Sex: All

Age: 18 - 70+

Code: NCT06390709

Recruiting

TEMPUS ARIES: A Biobank Registry Platform Study in Oncology

for
Cancer
Location: Whittier CA, Reno NV, Spokane WA, Springfield MO,
Sponsor: Tempus AI

Sex: All

Age: 18 - 70+

Code: NCT06207032

Recruiting

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

for
Breast Cancer
Location: Whittier CA, Fullerton CA, Santa Monica CA, Irvine CA,
Sponsor: Greenwich LifeSciences, Inc.

Sex: All

Age: 18 - 70+

Code: NCT05232916

Phase 3, Recruiting

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

for
Breast Cancer, TNBC - Triple-Negative Breast Cancer,
Location: Whittier CA, Reno NV, Spokane Valley WA, Sioux Falls SD,
Sponsor: Tempus AI

Sex: All

Age: 18 - 70+

Code: NCT07211178

Recruiting

A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

for
CLL, Chronic Lymphocytic Leukemia, SLL
Location: Whittier CA, Los Angeles CA, San Diego CA, Eugene OR,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06846671

Phase 3, Recruiting

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for
Triple Negative Breast Cancer
Location: Downey CA, Newport Beach CA, Los Angeles CA,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT05633654

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

for
Recurrent or Metastatic Solid Tumors
Location: Whittier CA, Los Angeles CA, Salt Lake City UT,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06330064

Phase 1, Phase 2, Recruiting